Evidence map›Paper›PMID 42244777›Full record

ArticlebioRxiv : the preprint server for biology2026

Decoding Multicellular Communication Motifs from Spatial Transcriptomics with ALARMIST.

Jiayi Fan, John Hood, James Strong, Jeffrey F Quinn, Yibo Dai, Data Science TeamLab, Aaron Schein, Kenny Kwok Hei Yu, Wesley Tansey

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jiayi FanComputational Oncology, Memorial Sloan Kettering Cancer Center.ORCID 0009-0003-7590-9606
John HoodDepartment of Statistics, University of Chicago.
James StrongDepartment of Neurosurgery, Memorial Sloan Kettering Cancer Center.
Jeffrey F QuinnComputational Oncology, Memorial Sloan Kettering Cancer Center.
Yibo DaiDepartment of Genomic Medicine, University of Texas MD Anderson Cancer Center.
Data Science TeamLab
Aaron ScheinDepartment of Statistics, University of Chicago.ORCID 0000-0002-5507-2904
Kenny Kwok Hei YuDepartment of Neurosurgery, Memorial Sloan Kettering Cancer Center.ORCID 0000-0002-2394-4990
Wesley TanseyComputational Oncology, Memorial Sloan Kettering Cancer Center.ORCID 0000-0002-5294-4228

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
The Center for Tumor-Immune Systems Biology at MSKCCU54CA274492 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI Christina S Leslie, Alexander Y Rudensky · 2022 to 2026
$16.3M
Probabilistic Multiscale Modeling of the Tumor MicroenvironmentR37CA271186 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI Wesley Tansey · 2023 to 2026
$2.7M
NCI NIH HHS P30 CA008748NCI NIH HHS R37 CA271186NCI NIH HHS U54 CA274492
6 · The paper itself

Abstract

Cellular organization is driven by recurrent, coordinated interactions between multiple cell types, each sending and receiving multiple signals. Existing computational methods for spatial profiling data consider only individual ligand-receptor interactions and fail to capture the higher-order interactions governing the tissue microenvironment. To address this gap, we developed ALARMIST (Assessment of Ligand And Receptor Motifs And Impacts in Spatial Transcriptomics), a probabilistic framework that infers interpretable multicellular communication patterns from spatial data. ALARMIST decomposes neighborhood-level signaling patterns into motifs: recurrent communication subnetworks involving multiple cell types and sets of enriched ligand-receptor interactions. For each cell, ALARMIST identifies its active motifs and estimates the downstream phenotypic effects of each motif on active cells. We applied alarmist to spatial datasets of lung adenocarcinoma (LUAD) and glioblastoma (GBM) to identify microenvironmental drivers of tumor progression. In paired LUAD and adenocarcinoma-in-situ (AIS) samples, ALARMIST identified an immune-active vascular motif at the tumor-normal boundary and implicated motif-active plasmacytoid dendritic cells as drivers of inflammation in early carcinogenesis. In matched low- and high-grade glioma samples, ALARMIST identified a hub-and-spoke motif centered on a malignant macrophage subpopulation, implicating a GRN-SORT1 signaling axis with a downstream impact gene set predictive of survival in low-grade glioma patients. Code for ALARMIST is available at https://github.com/tansey-lab/alarmist.

Identifiers

PMID42244777
PMCPMC13232169

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.